Paula Lorgelly and Bruce Hollingsworth (Lancaster University) have taken the role of joint National Organisers for the Health Economists’ Study Group.

What would be the price for an orphan drug that generate rates of return no greater/smaller than the industry average? Is it reasonable?

OHE staff recently attended ISPOR and HTAi international conferences. In this blog post, we share a selection of our presentations.

Meet some of the OHE team at the European Health Economics Association (EuHEA) 2018 conference in Maastricht, 11-14 July.

This paper demonstrates OHE’s expertise in valuing health outcomes, and its contribution to methods for improving the quality of health valuation data.

Meet some of the OHE team at any of three conferences taking place from 20-22 June: HESG, AES, and the PROMS Research Conference.

An exploration of the non‐iterative time trade‐off method to value health states – our new paper published in Health Economics

Meet some of the OHE team at the Health Technology Assessment International (HTAi) 2018 conference in Vancouver, 1-5 June.

OHE Lunchtime Seminar with Prof Peter Smith: ‘How can we evaluate the cost-effectiveness of health system strengthening? A platforms perspective’

Meet some of the OHE team at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2018 conference in Baltimore, 19-23 May.


Subscribe to RSS - Research